The Effect of Dydrogesterone on Sexual Function in Women With Endometriosis

Kanuni Sultan Suleyman Training and Research Hospital

Status: Completed

Conditions: Sexual Dysfunction; Endometriosis

Treatments: Drug: Dydrogesterone

Study type: Interventional

Funder types: Other

Identifiers

NCT04287205

endo-fsfi

Details and patient eligibility

About

This study aimed to assess the effects of dydrogesterone on sexual function in women with endometriosis using Female Function Sexual Index (FSFI).

Full description

Sexual dysfunction is an important outcome for patients with endometriosis. In this study, we compare the fsfi (female sexual function index) questions and the scores before and after dydrogesterone treatment in patients with endometriosis. We aim to measure the effect of dydrogesterone in patients with endometriosis.

Enrollment: 79 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• no history of malignancies,
• normal findings at gynecological examinations and transvaginal ultrasonography
• normal uterine size, normal cervical smear results,
• patients not use any contraception methods in the last 6 months

Exclusion criteria

• with a history of systemic and/or psychiatric diseases,
• gynecological pathologies (myoma uteri, endometriosis, uterine anomalies, existing genital infections)
• pelvic organ prolapse
• pelvic surgeries

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

79 participants in 1 patient group

women with endometriosis

Experimental group

Treatment:

Drug: Dydrogesterone